ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial
SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for…
4 years ago
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
SEOUL, South Korea & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#Gout--LG Chem recently announced that the Company has submitted…
4 years ago
Hong Kong Smart Design, Sparkle in Greater Bay Area 2022; Hong Kong Creative Industries Summit: Energize Borderless Opportunities
Gear up! Capture the Opportunities amid the Pandemic and Tap into Greater Bay Area Market…
4 years ago
Thailand Connected Trucks Telematics Market Analysis/Opportunities Report 2022 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Thailand Connected Trucks Telematics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.…
4 years ago
Propanc Biopharma Establishes Joint Research Collaboration Agreement with the Universities of Jaén and Granada
Research Evaluates Effects of Against the Tumor Microenvironment MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB)…
4 years ago
FirstWave Cloud’s Revolutionary Open Security Management Platform (OSMP) Delivers On “Urgent” Need For SMB Cyber Protection
SYDNEY, Australia--(BUSINESS WIRE)--#asx--Comprehensive cyber protection for SMBs has emerged as the next great revenue driver…
4 years ago
Rising Cost of Living Driving 1 in 2 Consumers to Cut Back on Spending, According to LoopMe Survey
Of nearly 18,000 consumers surveyed in U.S., U.K., and Australia, 67% do not want to…
4 years ago
OSI Systems’ Chief Executive Officer Appointed to U.S. – India CEO Forum
HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (NASDAQ: OSIS) announces that its Chairman and Chief Executive Officer,…
4 years ago
Shape Memory Medical Celebrates Treatment of 1,500th Patient
SANTA CLARA, Calif.--(BUSINESS WIRE)--#ShapeMemoryPolymer--Shape Memory Medical Inc., developer of shape memory polymer devices for peripheral…
4 years ago
OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration
SUWON, South Korea--(BUSINESS WIRE)--#AgeRelatedMacularDegeneration--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…
4 years ago